Crossfire Oncology logo
VerifiedBiotechnology Research· Founded 2021

Crossfire Oncology

Aberrant functioning of kinases is known to be an important driver in cancer. Targeting hereof has proven to be extremely successful and has already revolutionized the management of numerous types of cancer. At Crossfire Oncology we approach kinases from three different angles: inhibitors, degraders, and degrader antibody conjugates. This tailored approach allows us to design kinase targeting drugs that aim to maximize the therapeutic benefit for cancer patients.

7-day free trial · no credit card

HeadquartersOss Brabant, NetherlandsEmployees15(11 to 50)Founded year2021Websitecrossfire-oncology.comLinkedIn profileLinkedIn

Verified contacts

16

available on Kipplo

LinkedIn employees

15

11 to 50 range

Open roles

no listings

Distinct roles

12

indexed titles

Tech stack

0

tools in use

Monthly traffic

organic / mo

Sign up free to see all 16 verified contacts at Crossfire Oncology

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

16 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Crossfire Oncology

12 distinct titles indexed · top 10 shown.

  • 3senior scientist
  • 2scientist biology
  • 2senior scientist chemistry
  • 1ceo crossfire oncology
  • 1chief business officer
  • 1head of biology
  • 1head of chemistry
  • 1intern medicinal chemistry
  • 1research scientist chemistry
  • 1senior scientist analytics & crystallography
  • +2more titles

Sign up to unlock all 16 contacts at Crossfire Oncology

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 16 verified contacts at Crossfire Oncology

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Crossfire Oncology | Kipplo Discover